TargetMol

Venlafaxine

Product Code:
 
TAR-T22453
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T22453-5mg5mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22453-25mg25mg£132.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22453-50mg50mg£164.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22453-100mg100mg£210.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22453-200mg200mg£281.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Venlafaxine, an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI), is used to treat major generalised anxiety disorder (GAD), depressive disorder (MDD), panic disorder and social phobia.
CAS:
93413-69-5
Formula:
C17H27NO2
Molecular Weight:
277.408
Pathway:
Neuroscience
Purity:
0.9962
SMILES:
COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1
Target:
Serotonin Transporter

References

1. Singh J . Venlafaxine: more dangerous than most "selective" serotonergic antidepressants.[J]. prescrire international, 2016, 25(170):96. 2. Wang J L, Wang Y, Gao T T, et al. Venlafaxine protects against chronic stress-related behaviors in mice by activating the mTORC1 signaling cascade[J]. Journal of Affective Disorders. 2020, 276: 525-536.